Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Bayer

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Drugs|January 1, 1987
The memory clinic. A new approach to the detection of early dementiaA J Bayer, M S Pathy, C Twining
Diabetic Medicine : a Journal of the British Diabetic Association|August 19, 2014
Diabetes and dementia in older people: a Best Clinical Practice Statement by a multidisciplinary National Expert Working GroupA J Sinclair, R Hillson, A J Bayer, et al.
QJM : Monthly Journal of the Association of Physicians|March 22, 2001
Age and gender bias in statin trialsS Bandyopadhyay, A J Bayer, M S O'Mahony
Comprehensive Gerontology. Section A, Clinical and Laboratory Sciences|June 1, 1988
A geriatric high dependency unit--an innovation in the care of the acutely ill elderly patient?J J Day, A J Bayer, M S Pathy
Lancet (London, England)|June 27, 1987
Trials in acute strokeA J Bayer, M S Pathy, R G Newcombe
Age and Ageing|September 1, 1985
Cardiac arrests in a geriatric unitA J Bayer, B C Ang, M S Pathy
Pharmacoeconomics|May 27, 1999
A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impactM D Walker, S S Salek, A J Bayer
Pharmacoeconomics|May 27, 1999
A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effectsS S Salek, M D Walker, A J Bayer
Human Molecular Genetics|May 1, 1995
No evidence that common allelic variation in the Amyloid Precursor Protein (APP) gene confers susceptibility to Alzheimer's diseaseM B Liddell, A J Bayer, M J Owen
Pharmatherapeutica|January 1, 1983
An evaluation of the short-term hypnotic efficacy of loprazolam in comparison with nitrazepam in elderly patientsA J Bayer, M S Pathy, S I Ankier
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Drugs|January 1, 1987
The memory clinic. A new approach to the detection of early dementiaA J Bayer, M S Pathy, C Twining
Diabetic Medicine : a Journal of the British Diabetic Association|August 19, 2014
Diabetes and dementia in older people: a Best Clinical Practice Statement by a multidisciplinary National Expert Working GroupA J Sinclair, R Hillson, A J Bayer, et al.
QJM : Monthly Journal of the Association of Physicians|March 22, 2001
Age and gender bias in statin trialsS Bandyopadhyay, A J Bayer, M S O'Mahony
Comprehensive Gerontology. Section A, Clinical and Laboratory Sciences|June 1, 1988
A geriatric high dependency unit--an innovation in the care of the acutely ill elderly patient?J J Day, A J Bayer, M S Pathy
Lancet (London, England)|June 27, 1987
Trials in acute strokeA J Bayer, M S Pathy, R G Newcombe
Age and Ageing|September 1, 1985
Cardiac arrests in a geriatric unitA J Bayer, B C Ang, M S Pathy
Pharmacoeconomics|May 27, 1999
A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impactM D Walker, S S Salek, A J Bayer
Pharmacoeconomics|May 27, 1999
A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effectsS S Salek, M D Walker, A J Bayer
Human Molecular Genetics|May 1, 1995
No evidence that common allelic variation in the Amyloid Precursor Protein (APP) gene confers susceptibility to Alzheimer's diseaseM B Liddell, A J Bayer, M J Owen
Pharmatherapeutica|January 1, 1983
An evaluation of the short-term hypnotic efficacy of loprazolam in comparison with nitrazepam in elderly patientsA J Bayer, M S Pathy, S I Ankier
Pageof 5